Nkọwapụta Ụlọ ọrụ
Innovita Biological Technology Co., Ltd. (ya na ndị enyemaka ya, nke a na-akpọkarị "INNOVITA") bụ ụlọ ọrụ nkà na ụzụ na-elekwasị anya na nyocha, mmepe, mmepụta na ahịa nke ngwaahịa POCT in vitro diagnostic. Ọ mejupụtara Innovita (Tangshan) , Innovita (Beijing) na Innovita (Guangzhou).
● Tọrọ ntọala na 2006
● Tọọ ụlọ ọrụ R&D na Beijing na Guangzhou, yana ebe nrụpụta na Qian'an, Hebei.
Nkọwapụta Ụlọ ọrụ
Tọrọ ntọala na 2006, INNOVITA wuru isii teknụzụ nyiwe dị ka antigen & antibody nkwadebe, nje omenala, colloidal gold, ELISA, fluorescence chromatography, immunofluorescence, na-eme Chinese National High-tech R&D Mmemme na ubi nke mba isi ọrịa na-efe efe nnyocha na ọtụtụ. Ọrụ ahụike ọha ndị ọzọ.E wezụga nke ahụ, INNOVITA nwere ihe karịrị iri mba mepụtara patent ma tọọ elu Beijing R&D center, Guangzhou R&D center, Hebei mmepụta isi.Site na nnukwu ụlọ ọrụ dị ọcha, yana ịtọlite gold colloidal, ELISA, chromatography fluorescence, PCR, ahịrị mmepụta immunofluorescence, INNOVITA enwetala CE na ISO13485 asambodo.
Ka ọ dị ugbu a, ngwaahịa INNOVITA nwere nyocha nyocha nke iku ume, ule ọmụmụ, ule ịba ọcha n'anya, ule TORCH, nyocha obi obi, nyocha ọrụ gbasara akụrụ na ihe ndị ọzọ.Netwọk ahịa ahụ ekpuchila ógbè na mpaghara niile dị na China, wee gbasaa na Ndịda Ebe Ọwụwa Anyanwụ Eshia, Middle East, Africa, Latin America, European Union na mpaghara ndị ọzọ esenidụt.INNOVITA na-akwado nkà ihe ọmụma azụmahịa na-agbata ndị ahịa, ma na-enye ndị ahịa ahịa ngwaahịa ziri ezi ma dị mma karị.Mkpa nke ndị ahịa bụ nchụso nke INNOVITA.
Usoro mmepe
N'afọ 2006
N'afọ 2011
N'afọ 2014
N'afọ 2018
● Malitere imekọ ihe ọnụ nke mba ụwa.
N'afọ 2019
N'afọ 2020
● Ebupụ ya n'ihe karịrị mba/ebe iri asaa.
● Enyere mkpokọta Advanced Collective na National Commendation Congress maka ilụso ọrịa COVID-19 ọgụ.
● Nnwale COVID-19 IgM/IgG nwetara ikike iji ihe mberede (EUA) sitere na US FDA.
N'afọ 2022
Alaka
Beijing R&D & Marketing Center
Nhazi:2006
Gbado anya:R&D, nrụpụta, ire ngwaahịa diagnostic in-vitro, gụnyere nyiwe dị ka immunodiagnosis, nchoputa nke mkpụrụ ndụ ihe nketa, na ibe mkpụrụ ndụ ihe nketa.
Ụlọ nrụpụta Qian'an & Logistic
Nhazi:2011
Ihe owuwu:Na-ekpuchi mpaghara 150 acres, gburugburu 8,000 ㎡ ebe ogbako, kwadebere ọtụtụ ahịrị mmepụta nke ọla edo colloidal, ELISA, PCR.
Asambodo:ISO 13485, CE, FDA, NMPA, wdg.
Guangzhou R&D Center
Nhazi:2020
Gbado anya:R&D nke teknụzụ IVD
Platform
Netwọk ahịa
Mgbe ọtụtụ afọ nke mmepe gasịrị, Innovita enweelarị ahịa ahịa na netwọk ọrụ zuru oke, yana ọwa ahịa na-ekpuchi ógbè na mpaghara 32 n'ofe China, ma na-ebuga ya n'ahịa ụwa dị ka Southeast Asia, Middle East, Africa, Latin America, Europe, wdg.
Nnwale Innovita 2019-nCoV Ab gosipụtara n'elu ikpo okwu mberede mba maka ọgwụ na ngwaọrụ ahụike
Na February 28, 2020, Premier Li Keqiang nyochara ikpo okwu mberede mba maka ọgwụ na ngwaọrụ ahụike nke COVID-19.E gosipụtara Innovita 2019-nCoV Ab Test dị ka NMPA mbụ akwadoro IgM/IgG combo antibody test, nke akọọrọ na CCTV.
Nnwale Innovita 2019-nCoV Ab nke Academician Zhong Nanshan kpọrọ aha
● N'ehihie nke February 23, 2020, Academician Zhong Nanshan kpughere n'oge mkparịta ụka dịpụrụ adịpụ na Guangzhou na ndị otu ahụike Guangdong na-agba ọsọ iji nyere Jingzhou aka na National Medical Product Administration akwadola ngwa nyocha ọhụrụ abụọ maka 2019-nCoV, otu n'ime ha bụ. Emepụtara site na Innovita (Tangshan) Biological Technology Co., Ltd.
● Ngwa ahụ na-eji usoro ọla edo colloidal, nke nwere ike ịchọpụta ihe mgbochi lgM n'ime ahụ onye ọrịa.Enwere ike ịchọta ihe mgbochi lgM n'ụbọchị nke asaa nke ọrịa onye ọrịa ma ọ bụ ụbọchị nke atọ nke mmalite, nke na-enye aka nke ukwuu maka nchọpụta onye ọrịa ọzọ.Zhong Nanshan kwuru, sị: "Enwere ike ịmata ndị ọrịa ngwa ngwa maka ezigbo nchoputa. Nke a nwere ike inyere anyị aka ikewapụ ndị nkịtị ngwa ngwa na ndị bu ọrịa."
Ihe nrite mkpokọta dị elu
Na-alụso ọrịa ọgụ
